Rinat Tabakman

1.1k citations

25 papers · 892 indexed · h-index 16

Impact in

Developmental Neuroscience top 5%
- Neurogenesis and neuroplasticity mechanisms
Neurology top 5%
- Parkinson's Disease Mechanisms and Treatments
- Neuroinflammation and Neurodegeneration Mechanisms

Papers in

Cellular and Molecular Neuroscience 8
- Nerve injury and regeneration 8
Neurology 3
- Parkinson's Disease Mechanisms and Treatments 3
- Neuroinflammation and Neurodegeneration Mechanisms 2

Co-authors: Philip Lazarovici Ron Kohen Shimon Lecht Hadar Arien‐Zakay Robert A. Levine Hao Jiang Victoria Trembovler Eran Blaugrund
Journals: Journal of Clinical Oncology (3 papers)European Journal of Pharmacology (2 papers)Annals of the New York Academy of Sciences (2 papers)Experimental Neurology (1 paper)Nitric Oxide (1 paper)
Partner nations: Israel United States United Kingdom

In The Last Decade

Rinat Tabakman

25 papers receiving 872 citations

Peers

Countries citing papers authored by Rinat Tabakman

Since Specialization

Citations

This map shows the geographic impact of Rinat Tabakman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rinat Tabakman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rinat Tabakman more than expected).

Fields of papers citing papers by Rinat Tabakman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rinat Tabakman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rinat Tabakman. The network helps show where Rinat Tabakman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Rinat Tabakman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rinat Tabakman Line = papers co-authored together Rinat Tabakman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	51P Phase II dose expansion study of DSP107, a first-in-class fusion protein targeting CD47 and 4-1BB, in combination with atezolizumab in patients with advanced MSS colorectal cancer Annals of Oncology ·Ali Saeed, Kenza Belatrech, Babar Bashir, Alexander Philipovskiy, Harry B. Zackrison, R SH.AL-Khafajy, Rinat Tabakman, Yulia Shwartz, A. Moreira de Sá, Benjamin Bouchard	2024	1
2	Phase 1 dose escalation study of DSP107, a first-in-class CD47 and 4-1BB targeting fusion protein, in combination with atezolizumab in patients with advanced solid tumors. Journal of Clinical Oncology ·Anwaar Saeed, Babar Bashir, Jason J. Luke, Harry B. Zackrison, R SH.AL-Khafajy, Rinat Tabakman, Che Rameli, A. Moreira de Sá, Antonio Jimeno	2023	1
3	Phase 1 dose escalation study of DSP107, a first-in-class CD47 and 4-1BB targeting multifunctional immune-recruitment protein, in patients with advanced solid tumors. Journal of Clinical Oncology ·Jason J. Luke, Anwaar Saeed, Babar Bashir, Che Rameli, Rinat Tabakman, A. Moreira de Sá, Antonio Jimeno	2022	3
4	AGI-134: a fully synthetic α-Gal glycolipid that converts tumors into in situ autologous vaccines, induces anti-tumor immunity and is synergistic with an anti-PD-1 antibody in mouse melanoma models Cancer Cell International ·Stephen M. Shaw, Vladimir A. Tolstik, Kim Wigglesworth, Kuecuek Hatice Baspinar, Oliver Schulz, DO Andrew Wilson, Giles F. Whalen, Robert Old, Mike Westby, Chris Pickford, Rinat Tabakman, Irit Carmi-Levy, Rei-Fong Li, Ella Sorani, Malte Kleditzsch, Sascha A. Kristian	2019	12
5	BL-7010 Demonstrates Specific Binding to Gliadin and Reduces Gluten-Associated Pathology in a Chronic Mouse Model of Gliadin Sensitivity PLoS ONE ·Justin L. McCarville, Chad Mendelsohn, Heather J. Galipeau, Jennifer Jury, Rinat Tabakman, Joydipta Kar, 박미희, I. Chudaeva, Tatyana E. Novitskaya, Joseph A. Murray, Arivarasu Natarajan Anbazhagan, Pradeep K. Dudeja, Alexander Varvak, Jean‐Christophe Leroux, Elena F. Verdú	2014	42
6	A Pegylated Leptin Antagonist Ameliorates CKD-Associated Cachexia in Mice Journal of the American Society of Nephrology ·Wai W. Cheung, Wei Ding, А В Топорков, Yong Gu, Rinat Tabakman, Leah N. Klapper, Arieh Gertler, Robert H. Mak	2013	31
7	Pharmacokinetic and efficacy study of cisplatin and paclitaxel formulated in a new injectable poly(sebacic-co-ricinoleic acid) polymer European Journal of Pharmaceutics and Biopharmaceutics ·Etgar Levy‐Nissenbaum, Wahid Khan, Rajendra P. Pawar, Rinat Tabakman, 박미희, Fabiola Ramírez Flores, Racheal M. Erhard, Leah N. Klapper, Abraham J. Domb	2012	12
8	Improved muscle strength and mobility in the dy/dy mouse with merosin deficient congenital muscular dystrophy treated with Glatiramer acetate Neuromuscular Disorders ·Heyrani Tabasi Asieh, Shlomit Aga‐Mizrachi, M. L. Silva, Rinat Tabakman, Jiading Chen, Yakov Fellig, Emily Loyara Grilo Silva, Yoram Nevo	2010	14
9	The induction of tuftelin expression in PC12 cell line during hypoxia and NGF‐induced differentiation Journal of Cellular Physiology ·Yoav Leiser, Bojing Li, Anat Blumenfeld, Dekel Shilo, Amir Haze, Eli Rosenfeld, Boaz Shay, Rinat Tabakman, Shimon Lecht, Philip Lazarovici, D. Deutsch	2010	19
10	In vivo administration of BL-3050: highly stable engineered PON1-HDL complexes PubMed ·Leonid Gaidukov, W A Hawley, Shiri Yacobson, 박미희, Racheal M. Erhard, Rinat Tabakman, Dan S. Tawfik, Etgar Levy‐Nissenbaum	2009	35
11	Neuroprotection by cord blood neural progenitors involves antioxidants, neurotrophic and angiogenic factors Experimental Neurology ·Hadar Arien‐Zakay, Shimon Lecht, Cengiz Demir, Rinat Tabakman, Ron Kohen, Hanan Galski, Arnon Nagler, Philip Lazarovici	2008	67
12	Neuroprotective effects of the stable nitroxide compound Tempol on 1-methyl-4-phenylpyridinium ion-induced neurotoxicity in the Nerve Growth Factor-differentiated model of pheochromocytoma PC12 cells European Journal of Pharmacology ·Tatiana Lipman, Rinat Tabakman, Philip Lazarovici	2006	41
13	Neuroprotection by NGF in the PC12 In Vitro OGD Model: Involvement of Mitogen-Activated Protein Kinases and Gene Expression Annals of the New York Academy of Sciences ·Rinat Tabakman	2005	70
14	Nerve Growth Factor Pretreatment Attenuates Oxygen and Glucose Deprivation-Induced c-Jun Amino-Terminal Kinase 1 and Stress-Activated Kinases p38α and p38β Activation and Confers Neuroprotection in the Pheochromocytoma PC12 Model Journal of Molecular Neuroscience ·Rinat Tabakman, Hao Jiang, Erik Schaefer, Robert A. Levine, Philip Lazarovici	2004	35
15	Apoptotic characteristics of cell death and the neuroprotective effect of homocarnosine on pheochromocytoma PC12 cells exposed to ischemia Journal of Neuroscience Research ·Rinat Tabakman, Hao Jiang, Robert A. Levine, Ron Kohen, Philip Lazarovici	2004	42
16	Interactions between the cells of the immune and nervous system: neurotrophins as neuroprotection mediators in CNS injury Progress in brain research ·Rinat Tabakman, Shimon Lecht, Абдуллаев Ш. Р., Hadar Arien‐Zakay, Philip Lazarovici	2004	106
17	Neuroprotection by monoamine oxidase B inhibitors: a therapeutic strategy for Parkinson's disease? BioEssays ·Rinat Tabakman, Shimon Lecht, Philip Lazarovici	2003	50
18	Neuroprotective effects of carnosine and homocarnosine on pheochromocytoma PC12 cells exposed to ischemia Journal of Neuroscience Research ·Rinat Tabakman, Philip Lazarovici, Ron Kohen	2002	105
19	Neuroprotective and neurotoxic effects of monoamine oxidase-B inhibitors and derived metabolites under ischemia in PC12 cells European Journal of Pharmacology ·Amal Abdul Mahdi Kadhim, Rinat Tabakman, Eran Blaugrund, Victoria Trembovler, Philip Lazarovici	2002	81
20	Protein Kinase C-Independent Selective Induction of Nitric Oxide Synthase Activity in Rat Alveolar Macrophages by Staurosporine Nitric Oxide ·Rinat Tabakman, Philip Lazarovici, Yuzuru Matsuda, Chaya Brodie, Haim Ovadia	1998	7

About Rinat Tabakman

Rinat Tabakman is a scholar working on Cellular and Molecular Neuroscience, Neurology, Biophysics, Biotechnology and Behavioral Neuroscience, having authored 25 papers that have together received 892 indexed citations. Recurring topics across this work include Nerve injury and regeneration (8 papers), Cancer Research and Treatments (3 papers), Parkinson's Disease Mechanisms and Treatments (3 papers), Phagocytosis and Immune Regulation (3 papers), CAR-T cell therapy research (2 papers), Electron Spin Resonance Studies (2 papers), Adipose Tissue and Metabolism (2 papers) and Neuroinflammation and Neurodegeneration Mechanisms (2 papers). The work is most often cited by research in Developmental Neuroscience (104 citations), Neurology (138 citations), Cellular and Molecular Neuroscience (233 citations), Neurology (137 citations) and Behavioral Neuroscience (27 citations). Rinat Tabakman has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Philip Lazarovici, Ron Kohen, Shimon Lecht, Hadar Arien‐Zakay, Robert A. Levine, Hao Jiang, Victoria Trembovler, Eran Blaugrund, Tatiana Lipman and Iris Shahar. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Pharmacology, Annals of the New York Academy of Sciences, Experimental Neurology and Nitric Oxide.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact